MAPT and Cognitive impairment: We aimed to evaluate correlation of tau tracer retention with neuropsychological performance across the Alzheimer's disease (AD) continuum and non-AD tauopathies.<h4>Methods</h4>This study enrolled 178 patients with cognitive impairment and 60 volunteers.